Sangeetha S Portfolio: 107 Stocks Across Rs 529 Crore

Sangeetha S’s disclosed equity portfolio is worth Rs 529.33 crore, spread across a striking 107 stocks, according to Trendlyne’s Superstar Portfolio tracker. That is one of the most diversified portfolios among tracked investors, and the value has grown 24.43% over the latest quarter.

Here is a full look at what this unusually spread-out portfolio contains and what that level of diversification typically signals.

An Exceptionally Diversified Portfolio

Holding 107 different stocks is rare, even among actively managed Superstar Portfolios. Most tracked investors, even diversified ones, tend to hold anywhere from a dozen to around 70 stocks. A count above 100 puts this portfolio at the far end of the diversification spectrum.

With Rs 529.33 crore spread across 107 positions, the average position size is small relative to the total portfolio value, which is a hallmark of an investing style built on spreading small stakes across many companies rather than concentrating capital in a few high-conviction bets.

Portfolio Value and Recent Performance

The disclosed portfolio value stands at Rs 529.33 crore as of the latest quarterly filing, up 24.43% over the quarter. That is a solid gain, and with 107 stocks in the mix, it reflects broad-based performance across a wide basket rather than the fortunes of just one or two companies.

Sector Allocation: A Fairly Even Three-Way Split

The top three sectors are unusually close in weight to one another:

Sector	Weight
Chemicals & Petrochemicals	16.36%
Healthcare	16.23%
Metals & Mining	15.84%

Unlike many other tracked portfolios where one sector clearly dominates, here the top three sectors sit within half a percentage point of each other. Chemicals and petrochemicals leads narrowly at 16.36%, followed closely by healthcare at 16.23% and metals and mining at 15.84%. Together these three make up roughly 48% of the portfolio, with the remaining slice spread across many other industries given the 107-stock count.

This even spread across sectors, combined with the sheer number of holdings, points to a genuinely diversified approach rather than a portfolio built around one or two strong sector convictions.

Top Holdings

The three largest disclosed positions are:

Lotus Eye Hospital and Institute – Rs 85.78 crore
Pondy Oxides & Chemicals – Rs 56.57 crore
Mufin Green Finance – Rs 35.47 crore

Lotus Eye Hospital and Institute operates in specialized eye care hospital services. Pondy Oxides & Chemicals is involved in metal recycling and chemical manufacturing, fitting the portfolio’s broader chemicals and metals sector exposure. Mufin Green Finance operates in the non-banking financial services space, with a focus on green and sustainable finance themes.

Even the largest holding, Lotus Eye Hospital and Institute, makes up only about 16% of the total portfolio value, which is a very different concentration profile compared to portfolios where the top holding alone can account for 40% or more of total value.

Recent Buying Activity

The latest filing shows one clear disclosed addition:

Lotus Eye Hospital and Institute: increased by 6.84%

This is a meaningful increase in what is already the portfolio’s largest holding, suggesting growing conviction in this specific healthcare business even within an otherwise extremely spread-out portfolio.

Recent Selling Activity

The disclosed trims in the latest filing include:

Lippi Systems: reduced by 1.63%
Mayur Leather Products: reduced by 1.45%
Nexome Capital Markets (SMIFS): reduced by 0.91%

These are relatively larger percentage trims compared to some of the other portfolios in this batch, though they still represent adjustments within a small handful of the 107 total holdings.

What 107 Stocks Signals About Investing Style

A portfolio this spread out generally reflects one of a few investing approaches:

Deep diversification for risk reduction: Spreading capital across many companies to reduce the impact of any single stock’s poor performance.
A research-driven, opportunistic style: Taking smaller stakes across many companies as opportunities are identified, rather than committing large capital to a few names.
Long accumulated positions over time: A large stock count can also build up gradually over years as new small positions are added without necessarily exiting older ones.

Given the near even three-way sector split and the sheer number of holdings, this portfolio reads as a broadly diversified, actively researched approach rather than one built around a single strong sector thesis.

The Trade-Off Behind Extreme Diversification

Spreading a portfolio across 107 stocks reduces the risk that any single company’s bad news can meaningfully hurt overall returns. But it also means that no single winning stock can move the needle much either, since each position is a small fraction of the whole.

This is a fundamentally different risk and reward trade-off compared to concentrated portfolios covered elsewhere in Superstar Portfolio data. Diversification here works more like an index-like approach spread across specific stock selections, rather than a few big directional bets.

Chemicals, Healthcare, and Metals: What This Sector Mix Suggests

The near-even split between chemicals and petrochemicals, healthcare, and metals and mining is worth noting on its own. These three sectors do not typically move together in lockstep, which means the portfolio’s overall returns are not overly dependent on one specific economic cycle.

Chemicals and petrochemicals companies are often linked to industrial demand, export markets, and input costs like crude oil derivatives. Healthcare businesses, from hospitals to pharmaceutical companies, tend to see more stable, less cyclical demand. Metals and mining companies are typically tied to commodity price cycles and infrastructure or manufacturing activity.

Holding meaningful weight across all three, rather than picking just one, suggests a deliberate attempt to avoid being overly dependent on any single economic theme playing out. Combined with the 107-stock spread, this points to a portfolio built for balance across both individual company risk and broader sector or macroeconomic risk at the same time.

How Superstar Portfolio Data Works

Trendlyne’s Superstar Portfolio tracker is built on India’s shareholding disclosure rules, which require public disclosure once an individual’s stake in a listed company crosses 1% ownership. Some important caveats apply here as with any Superstar Portfolio entry:

Quarterly lag: The data reflects the latest quarterly filing, not real-time market values.
Only 1% plus stakes shown: Given 107 disclosed holdings already, there could be even more smaller positions below this threshold that remain invisible.
No entry price or timing shown: You cannot calculate actual returns from this data alone.
A research starting point: With this many holdings, the data is best used to understand broad sector tilts rather than any single stock decision.

Frequently Asked Questions

How many stocks does Sangeetha S hold according to Superstar Portfolio data?
107 stocks, one of the highest stock counts among tracked Superstar Portfolio investors, with a combined disclosed value of Rs 529.33 crore.

What is Sangeetha S’s largest holding?
Lotus Eye Hospital and Institute is the top holding at Rs 85.78 crore, followed by Pondy Oxides & Chemicals and Mufin Green Finance.

Which sector has the highest weight in this portfolio?
Chemicals and petrochemicals leads narrowly at 16.36%, closely followed by healthcare at 16.23% and metals and mining at 15.84%.

Why would an investor hold 107 different stocks?
Such extreme diversification typically reflects a risk-reduction strategy, an opportunistic research-driven style of taking many small stakes, or positions accumulated gradually over a long period.

Has Sangeetha S made any notable recent trades?
Yes, Lotus Eye Hospital and Institute was increased by 6.84% in the latest filing, while Lippi Systems, Mayur Leather Products, and Nexome Capital Markets (SMIFS) were trimmed.

Key Takeaways

Sangeetha S’s disclosed portfolio is worth Rs 529.33 crore across 107 stocks, up 24.43% over the latest quarter.
Sector weights are unusually balanced, with chemicals and petrochemicals (16.36%), healthcare (16.23%), and metals and mining (15.84%) close together.
Top holdings are Lotus Eye Hospital and Institute, Pondy Oxides & Chemicals, and Mufin Green Finance.
Lotus Eye Hospital and Institute was increased by 6.84% in the latest disclosed filing.
Trims were made in Lippi Systems, Mayur Leather Products, and Nexome Capital Markets (SMIFS).
The 107-stock spread suggests a highly diversified, small-stake investing approach rather than concentrated conviction bets.
Superstar Portfolio data reflects only disclosed 1% plus stakes on a quarterly lag and should be treated as a research tool, not investment advice.

Sangeetha S Portfolio: 107 Stocks Across Rs 529 Crore